Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2023 年第 2 季持倉
持倉截至 2023/6/30，2023/8/14 申報。只含多頭部位，變化是跟 2023 年第 1 季比股數。
- 持股檔數
- 55
- 較 2023 年第 1 季 +3
- 總值
- $2.77 億
- 較 2023 年第 1 季 +$1,277 萬 (+4.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TGTXTG Therapeutics, Inc. | COM | 825,000 | $2,049 萬 | 7.4% | −275,000−25.0% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 330,000 | $1,683 萬 | 6.1% | +135,000+69.2% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 360,000 | $1,681 萬 | 6.1% | +85,000+30.9% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 180,000 | $1,640 萬 | 5.9% | +15,380+9.3% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 280,000 | $1,398 萬 | 5.0% | +55,000+24.4% | 加碼 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 525,000 | $1,329 萬 | 4.8% | +275,000+110.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 55,000 | $1,271 萬 | 4.6% | +25,000+83.3% | 加碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 550,000 | $1,186 萬 | 4.3% | +75,000+15.8% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 650,000 | $1,054 萬 | 3.8% | +50,000+8.3% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 85,000 | $973.4 萬 | 3.5% | +25,000+41.7% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 100,000 | $892.5 萬 | 3.2% | −10,000−9.1% | 減碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 85,000 | $866.7 萬 | 3.1% | +15,000+21.4% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 110,000 | $790.5 萬 | 2.9% | −115,000−51.1% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 350,000 | $732.5 萬 | 2.6% | +25,000+7.7% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 200,000 | $722.6 萬 | 2.6% | +60,000+42.9% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 185,000 | $712.3 萬 | 2.6% | −15,000−7.5% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 575,000 | $680.8 萬 | 2.5% | +25,000+4.5% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 225,000 | $621.5 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 240,000 | $571.0 萬 | 2.1% | +65,000+37.1% | 加碼 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 190,000 | $417.1 萬 | 1.5% | +70,000+58.3% | 加碼 | 歷史 |
| INCYIncyte Corp | COM | 65,000 | $404.6 萬 | 1.5% | −10,000−13.3% | 減碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 22,500 | $401.2 萬 | 1.4% | +22,500 | 新進 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 238,225 | $392.1 萬 | 1.4% | −11,775−4.7% | 減碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 150,000 | $367.9 萬 | 1.3% | +150,000 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 347,432 | $357.2 萬 | 1.3% | +147,432+73.7% | 加碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 201,197 | $345.1 萬 | 1.2% | +1,197+0.6% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 100,000 | $282.1 萬 | 1.0% | +100,000 | 新進 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $271.1 萬 | 1.0% | −5,000−28.6% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 150,000 | $271.1 萬 | 1.0% | +70,000+87.5% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 200,000 | $251.2 萬 | 0.9% | −275,000−57.9% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 300,173 | $250.0 萬 | 0.9% | −149,827−33.3% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 215,000 | $246.4 萬 | 0.9% | −160,000−42.7% | 減碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 20,000 | $234.8 萬 | 0.8% | +20,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 110,000 | $232.5 萬 | 0.8% | +110,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 154,250 | $220.9 萬 | 0.8% | +154,250 | 新進 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 412,699 | $192.7 萬 | 0.7% | +62,699+17.9% | 加碼 | 歷史 |
| IMGNImmunoGen, Inc. | COM | 100,000 | $188.7 萬 | 0.7% | −24,977−20.0% | 減碼 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 280,981 | $175.9 萬 | 0.6% | +280,981 | 新進 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 250,000 | $171.0 萬 | 0.6% | +100,000+66.7% | 加碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 75,000 | $152.3 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 75,000 | $149.0 萬 | 0.5% | +75,000 | 新進 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 200,000 | $140.8 萬 | 0.5% | −75,000−27.3% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 20,000 | $114.7 萬 | 0.4% | +20,000 | 新進 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 35,000 | $90.9 萬 | 0.3% | +35,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 27,578 | $72.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 42,000 | $72.2 萬 | 0.3% | +17,000+68.0% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 65,000 | $72.1 萬 | 0.3% | −60,000−48.0% | 減碼 | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 100,000 | $70.4 萬 | 0.3% | −900,000−90.0% | 減碼 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 16,675 | $67.8 萬 | 0.2% | +16,675 | 新進 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 64,000 | $64.5 萬 | 0.2% | +64,000 | 新進 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 325,000 | $39.0 萬 | 0.1% | +75,000+30.0% | 加碼 | – |
| REPLReplimune Group, Inc. | COM | 10,865 | $25.2 萬 | 0.1% | +10,865 | 新進 | 歷史 |
| VNDAVanda Pharmaceuticals Inc. | COM | 31,000 | $20.4 萬 | 0.1% | +18,500+148.0% | 加碼 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 61,250 | $20.2 萬 | 0.1% | +61,250 | 新進 | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 36,500 | $9.86 萬 | <0.1% | +10,000+37.7% | 加碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $2,496 萬 |
| BTAIQBioXcel Therapeutics, Inc. | COM | – | $86.6 萬 |
2023 年第 1 季之後清倉（11 檔）
2023 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 1 季股數 | 2023 年第 1 季市值 | 2023 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CTICCti Biopharma Corp | COM | 2,000,000 | $840.0 萬 | 3.2% | 歷史 |
| PFEPfizer Inc | Stock | 200,000 | $816.0 萬 | 3.1% | 歷史 |
| JNJJohnson & Johnson | Stock | 50,000 | $775.0 萬 | 2.9% | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 175,000 | $425.8 萬 | 1.6% | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 425,000 | $343.8 萬 | 1.3% | 歷史 |
| ETNB89bio, Inc. | COM | 200,000 | $304.6 萬 | 1.2% | 歷史 |
| IRONDisc Medicine, Inc. | COM | 100,000 | $211.9 萬 | 0.8% | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 15,000 | $161.0 萬 | 0.6% | 歷史 |
| GERNGeron Corp | COM | 450,000 | $97.7 萬 | 0.4% | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 850,000 | $74.0 萬 | 0.3% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 175,000 | $54.8 萬 | 0.2% | 歷史 |